6,183
Views
142
CrossRef citations to date
0
Altmetric
Original Research Article

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

, , , , , & show all
Article: 1294368 | Received 28 Jun 2016, Accepted 06 Dec 2016, Published online: 28 Feb 2017

References

  • Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:1–12. PubMed PMID: 25288114. DOI:10.1146/annurev-cellbio-101512-122326
  • Bobrie A, Colombo M, Raposo G, et al. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12(12):1659–1668. Epub 2011 Jun 08. PubMed PMID: 21645191. DOI:10.1111/j.1600-0854.2011.01225.x
  • Ludwig AK, Giebel B. Exosomes small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012;44(1):11–15. Epub 2011 Oct 26. PubMed PMID: 22024155. DOI:10.1016/j.biocel.2011.10.005
  • Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–593. PubMed PMID: 19498381. DOI:10.1038/nri2567
  • Raimondo F, Morosi L, Chinello C, et al. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics. 2011;11(4):709–720. PubMed PMID: 21241021. DOI:10.1002/pmic.201000422
  • Choi D-S, Kim D-K, Kim Y-K, et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics. 2013;13(10–11):1554–1571. PubMed PMID: 23401200. DOI:10.1002/pmic.201200329
  • Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015;107:7. PubMed PMID: 25972604; PMCID: PMC4651042. DOI:10.1093/jnci/djv135
  • Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. PubMed PMID: 17486113. DOI:10.1038/ncb1596
  • Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78(9):838–848. Epub 2010 Aug 13. PubMed PMID: 20703216. DOI:10.1038/ki.2010.278
  • Greening DW, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179–209. PubMed PMID: 25820723. DOI:10.1007/978-1-4939-2550-6_15
  • Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031. PubMed PMID: 26194179; PMCID: PMC4507751. DOI:10.3402/jev.v4.27031
  • Heinemann ML, Ilmer M, Silva LP, et al. Benchtop isolation and characterization of functional exosomes by sequential filtration. J Chromatogr A. 2014;1371:125–135. PubMed PMID: 25458527. DOI:10.1016/j.chroma.2014.10.026
  • Tan CY, Lai RC, Wong W, et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5(3):76. PubMed PMID: 24915963; PMCID: PMC4229780. DOI:10.1186/scrt465
  • Davies RT, Kim J, Jang SC, et al. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab on a Chip. 2012;12(24):5202–5210. PubMed PMID: 23111789. DOI:10.1039/c2lc41006k
  • Kordelas L, Rebmann V, Ludwig AK, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28(4):970–973. PubMed PMID: 24445866. DOI:10.1038/leu.2014.41
  • Balaj L, Atai NA, Chen W, et al. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015;5:10266. PubMed PMID: 25988257; PMCID: 4437317. DOI:10.1038/srep10266
  • Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113(8):E968- E977. PubMed PMID: 26858453; PMCID: PMC4776515. DOI:10.1073/pnas.1521230113
  • Böing AN, Van Der Pol E, Grootemaat AE, et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3. PubMed PMID: 25279113; PMCID: PMC4159761. DOI:10.3402/jev.v3.23430
  • Carotta S. Targeting NK cells for anticancer immunotherapy: clinical and preclinical approaches. Front Immunol. 2016;7:152. PubMed PMID: 27148271; PMCID: PMC4838611. DOI:10.3389/fimmu.2016.00152
  • Lugini L, Cecchetti S, Huber V, et al. Immune surveillance properties of human NK cell-derived exosomes. J Immunol. 2012;189(6):2833–2842. Epub 2012 Aug 21. PubMed PMID: 22904309. DOI:10.4049/jimmunol.1101988
  • Fais S. NK cell-released exosomes: natural nanobullets against tumors. Oncoimmunology. 2013;2(1):e22337. Epub 2013 Mar 14. PubMed PMID: 23482694; PMCID: 3583913. DOI:10.4161/onci.22337
  • Liu Y, Wu HW, Sheard MA, et al. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy. Clin Cancer Res. 2013;19(8):2132–2143. Epub 2013 Feb 05. PubMed PMID: 23378384; PMCID: PMC3658308. DOI:10.1158/1078-0432.CCR-12-1243
  • Zhang H, Cui Y, Voong N, et al. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother. 2011;34(2):187–195. Epub 2011 Feb 10. PubMed PMID: 21304401; PMCID: 3128544. DOI:10.1097/CJI.0b013e31820d2a21
  • Fais S, Logozzi M, Lugini L, et al. Exosomes: the ideal nanovectors for biodelivery. Biol Chem. 2013;394(1):1–15. Epub 2012 Dec 18. PubMed PMID: 23241589t. DOI:10.1515/hsz-2012-0236
  • Denman CJ, Senyukov VV, Somanchi SS, et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. Plos One. 2012;7(1):e30264. Epub 2012 Jan 27. PubMed PMID: 22279576; PMCID: 3261192. DOI:10.1371/journal.pone.0030264
  • Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014;3:26913. PubMed PMID: 25536934; PMCID: PMC4275645.
  • Fei F, Lim M, George AA, et al. Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells. Leukemia. 2015;29(4):788–797. PubMed PMID: 25134458; PMCID: PMC4334757. DOI:10.1038/leu.2014.246
  • Krzewski K, Coligan JE. Human NK cell lytic granules and regulation of their exocytosis. Front Immunol. 2012;3:335. PubMed PMID: 23162553; PMCID: PMC3494098. DOI:10.3389/fimmu.2012.00335
  • Hsu HT, Orange JS. Distinct integrin-dependent signals define requirements for lytic granule convergence and polarization in natural killer cells. Sci Signal. 2014;7(346):pe24. PubMed PMID: 25292212. DOI:10.1126/scisignal.2005816
  • Kaspar AA, Okada S, Kumar J, et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol. 2001;167(1):350–356. PubMed PMID: 11418670.
  • Saini RV, Wilson C, Finn MW, et al. Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells. J Immunol. 2011;186(6):3497–3504. Epub 2011 Feb 08. PubMed PMID: 21296981. DOI:10.4049/jimmunol.1003409
  • Ewen CL, Kane KP, Bleackley RC. A quarter century of granzymes. Cell Death Differ. 2012;19(1):28–35. PubMed PMID: 22052191; PMCID: PMC3252830. DOI:10.1038/cdd.2011.153
  • Lieberman J. Granzyme A activates another way to die. Immunol Rev. 2010;235(1):93–104. PubMed PMID: 20536557; PMCID: PMC2905780. DOI:10.1111/j.0105-2896.2010.00902.x
  • Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis? Annu Rev Immunol. 1991;9:129–157. PubMed PMID: 1910674. DOI:10.1146/annurev.iy.09.040191.001021
  • Shah NN, Baird K, Delbrook CP, et al. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation. Blood. 2015;125(5):784–792. PubMed PMID: 25452614; PMCID: PMC4311226. DOI:10.1182/blood-2014-07-592881
  • Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383–2390. Epub 2013 Dec 19. PubMed PMID: 24345736. DOI:10.1016/j.biomaterials.2013.11.083
  • Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated antiinflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19:1769–1779. [PMID: 21915101]